GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: CCT361814 | compound 22 [PMID: 37017629] | NXP-800
Compound class:
Synthetic organic
Comment: NXP800 (CCT361814) was identified as an orally bioavailable heat shock factor 1 (HSF1) pathway inhibitor in a phenotypic screen [3]. It was proposed for anti-proliferative activity in tumours. Subsequent studies identified NXP800 as an activator of the GCN2 (general control nonderepressible 2) kinase that phosphorylates eukaryotic translation initiation factor 2 alpha (EIF2α) [2]. This activity promotes selective ATF4-mediated transcription of genes involved in the integrated stress response (ISR), ultimately leading to apoptosis of tumour cells [4].
|
|
Bioactivity Comments |
Preclinically, anti-proliferative activity has been established in cholangiocarcinoma cell lines, and antitumour activity has been demonstrated in patient derived xenograft models of human cholangiocarcinoma [1,3]. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|